LON:CHRT - Cohort PLC
Executive Summary
Cohort PLC (LON:CHRT) is a United Kingdom-domiciled defence and security group operating through four subsidiaries: MASS (electronic warfare and surveillance), EID (military communications), SOE (sonar and acoustic systems), and ASV (autonomous systems). The company serves UK Ministry of Defence customers, European defence ministries, and NATO-aligned governments, generating revenue from long-term contracts for sovereign defence capability. As a small-cap defence technology group, Cohort occupies a niche in electronic warfare, maritime sensing, and unmanned systems, categories that align with stated UK and European defence procurement priorities. The company reported record first-half 2026 revenue of £128.8 million, though the current share price of 12.74p reflects an elevated trailing P/E of approximately 32.34 times, suggesting the market is pricing in meaningful future earnings delivery with limited near-term hard catalysts to confirm or disprove that thesis. The investment case rests on Cohort converting its reported strong order book into contract awards and margin expansion over the next twelve to eighteen months; a delay or reduction in expected UK or European defence procurement cycles represents the primary risk to that thesis. OPPORTUNISTIC BUY. Conviction Score: 59/100. A significant contract win or strategic acquisition would shift the sentiment and potentially re-rate the stock above the 52-week high of 17.96p, while a sustained contraction in defence spending or order book weakness would warrant immediate reassessment.
Business Model
Cohort PLC operates as a holding company for four specialist defence subsidiaries, each serving distinct capability domains and customer bases. This structure allows the group to diversify revenue across land, maritime, air, cyber, and joint operational domains while maintaining operational autonomy within each subsidiary. Revenue is generated primarily through long-term defence contracts with government ministries, predominantly the UK MOD and allied European defence establishments, with a meaningful export component. Contract structures typically span multiple years, providing revenue visibility, though award timing introduces variability into period-by-period performance. The group announced record first-half 2026 revenue of £128.8 million, suggesting improving scale, though the disclosure of concurrent profitability challenges indicates that revenue growth has not uniformly translated into margin expansion. The electronic warfare and communications segments represent the most established revenue contributors, while the autonomous systems and sonar divisions serve higher-growth but currently smaller portions of group revenue. Cohort's competitive moat rests on sovereign capability arguments — governments prefer domestically produced defence technology for classified programmes — combined with established relationships and cleared personnel that create meaningful barriers to displacement by foreign competitors. As a sub-£300 million market capitalisation defence group, Cohort occupies a space where larger prime contractors may overlook niche programmes but where Cohort's subsidiaries possess established technical credentials and customer trust.
Financial Snapshot
Recent Catalysts
January 2026 — Cohort published an investor presentation reporting record revenue, a strong order book, and positive momentum in global demand for the group's defence capabilities. Management communicated an optimistic outlook and indicated expectations for continued margin growth across the group. Source: Quartr investor event summary.
November 2025 — The company issued an update reporting record revenue, profit, and order book levels, underscoring the breadth of demand across its subsidiary portfolio. This announcement established the baseline from which the subsequent January 2026 investor presentation built. Source: Quartr event summary.
April 2026 — Cohort PLC stock crossed above its 200-day moving average of 1,264.41p, a technically significant event that attracted commentary in specialist defence sector publications. The 50-day moving average stood above the 200-day, indicating short-term upward price momentum for the share. Source: Defence World.
9 April 2026 — Chief executive Andrew Thomis completed a routine director share transaction described as a "Bed and ISA" arrangement, adjusting his personal shareholding in line with standard corporate governance practice. Director dealings of this nature are disclosed under PDMR reporting rules and reflect individual portfolio management rather than a directional signal on company prospects. Source: Investegate regulatory announcement.
April 2026 — Cohort filed an update to its block listing in connection with employee share option exercises, reflecting ongoing equity incentive activity within the group. This administrative filing confirmed continued use of share-based compensation but did not convey information about the scale of the available pool. Source: TipRanks company announcement summary.
Thesis Evaluation
Bull Case (25% weight)
Cohort converts its reported strong order book into a sequence of material contract awards over the next twelve months, with each subsidiary securing at least one contract exceeding £20 million in value. UK MOD and NATO-aligned procurement cycles accelerate in response to evolving geopolitical priorities, justifying a re-rating to a forward P/E of approximately 22 times on consensus 2027 earnings. The stock breaks through the 52-week high of 17.96p and advances toward 22.00p within eighteen months, driven by upgraded analyst coverage and increased institutional buying as defence spending headlines improve. This scenario requires no deterioration in profitability and assumes Cohort's export pipeline converts at historical conversion rates.
Base Case (50% weight)
Cohort reports full-year 2026 results broadly in line with current market expectations — record revenue confirmed with gradual margin recovery — and the order book remains stable at currently disclosed levels. No material new contract announcements emerge in the near term, keeping the P/E at approximately 32 times earnings. The shares trade within a range of 11.00p to 16.00p for the next twelve months as the market awaits either a contract announcement or further evidence of margin improvement. The current price of 12.74p represents a fair entry point for long-term holders willing to accept limited near-term capital appreciation in exchange for exposure to a structurally supported defence technology business. 17.96p within twelve months reflects a return to the 52-week high on steady execution, consistent with a market that is neither upgrading nor downgrading the earnings thesis.
Bear Case (25% weight)
Cohort's elevated trailing P/E of 32.34 times is not supported by near-term earnings if contract timing slips or margin pressure intensifies, prompting a de-rating toward sector average multiples. The order book, while described as strong in corporate communications, fails to produce verifiable contract wins within six months, leading analysts to reduce earnings estimates and the shares to fall below the current price. A scenario where FY2026 earnings disappoint consensus and the P/E compresses to 20 times would imply a share price of approximately 8.50p, approaching the 52-week low of 8.81p. This downside scenario is most likely triggered by a combination of UK MOD budget reallocation and a failure to convert export pipeline in the near term. The risk of capital impairment is material if the valuation contraction coincides with a period of sector-wide derating.
Key Risks
- Valuation Re-Rating Risk: The stock trades on a trailing P/E of approximately 32.34 times, a premium that requires consistent delivery of contract awards and earnings growth to sustain; if results disappoint or order intake slows, the de-rating could be abrupt and severe. Estimated probability: 35%. Impact: severe.
- Contract Concentration and Award Timing Risk: Cohort's order book visibility is tied to a limited number of large government contracts, and delays in UK MOD or allied defence ministry procurement cycles can cause material revenue shortfalls in specific reporting periods. Estimated probability: 40%. Impact: moderate.
- Margin and Profitability Pressure: The H1 2026 record revenue of GBP128.8 million was accompanied by disclosed profitability challenges, suggesting that top-line growth is not automatically translating into improved operating margins. Estimated probability: 30%. Impact: moderate.
- Liquidity and Scale Constraints: With a market capitalisation of approximately GBP280 million, Cohort lacks the analyst coverage, trading liquidity, and balance sheet capacity of larger defence primes, limiting the institutional investor base and potentially widening bid-ask spreads during periods of market stress. Estimated probability: 25%. Impact: low.
- Geopolitical and Defence Budget Risk: Although UK defence spending is ring-fenced relative to other government expenditure categories, any material reallocation of the defence budget away from electronic warfare, maritime, or autonomous systems — the areas where Cohort's subsidiaries operate — would directly impair revenue visibility. Estimated probability: 20%. Impact: severe.
Who Should Own It / Avoid It
Ideal for: long-term oriented private investors and institutional allocators with a genuine defence sector allocation seeking exposure to niche UK and European defence technology at small-cap scale. A minimum holding period of three to five years is appropriate given the contract-driven revenue model and limited near-term catalysts. Risk tolerance should be moderate to high; investors must accept that the current elevated P/E may not compress without a material catalyst, and that sector derating or contract delays can produce meaningful drawdowns in the interim. Conviction on sovereign defence capability as a structural investment theme is a prerequisite.
Avoid if: you require near-term price appreciation, liquid exit options, or income from a defence sector holding. The stock's limited analyst coverage and small-cap status mean that price discovery can be slow and that the bid-ask spread may be wider than on mid-cap or large-cap peers. If your portfolio construction framework cannot accommodate positions with no near-term hard catalysts and a trailing P/E of 32.34 times in a declining or neutral sentiment environment, Cohort PLC at 12.74p is not appropriate at this time. Passive income investors and those with short investment time horizons should not hold this position.
Recommendation
OPPORTUNISTIC BUY — 59/100. The current neutral sentiment — reflecting an absence of hard catalysts such as contract announcements or strategic deals — is precisely what defines the OPPORTUNISTIC BUY tier: a company with genuine structural tailwinds and visible order book strength, but one whose near-term share price performance will be driven by catalyst timing rather than earnings momentum. The record H1 2026 revenue figure and the positive tone of the January 2026 investor presentation provide a credible earnings foundation, while the 200-day moving average crossover in April 2026 suggests technically driven buying interest is present. An upgrade to a full BUY would require either a confirmed contract win exceeding £20 million or an analyst initiation with a price target materially above the current 52-week high of 17.96p; degradation of the call would follow any profit warning, order book commentary revision, or sector-wide de-rating that pushes the stock meaningfully below 10.00p on a sustained basis.
below 13.38p — at 5% above the current price of 12.74p, appropriate for an OPPORTUNISTIC BUY conviction tier where the absence of near-term catalysts justifies a modest entry premium.
between 13.38p and 16.00p — a zone that captures the stock's likely trading range as the market awaits contract announcements or confirmation of margin recovery; investors who accumulate here should be prepared for a holding period of six to twelve months before a further re-rating catalyst materialises.
above 16.00p and above 17.96p — the 52-week high represents a technically and fundamentally significant resistance level; above this zone, the stock would be pricing in a bull case that is not currently supported by confirmed contract pipeline, and taking partial profits is warranted. Stop loss below 8.80p if the position is held as a core allocation; below this level, the 52-week low has been breached and fundamental reassessment of the earnings thesis would be required before considering re-entry.
Conviction Trend
Latest conviction: 59/100. Trend versus prior report: Initiation.
| Report date | Conviction |
|---|---|
| 2026-04-27 | 59 |
Sources
Market data: DYOR HQ proprietary market data workflow.
Public sentiment and news flow: DYOR HQ aggregated and processed available public news flow, company earnings presentations and investor event summaries, regulatory filings including PDMR and block listing announcements, and third-party financial news commentary covering Cohort PLC. Sentiment signals were derived from the corpus of recent company-announced events and publicly available analyst commentary on the defence sector.
Primary source types: Public company announcements via Investegate regulatory news service; investor relations materials and investor event summaries published by Cohort PLC; earnings call highlights and financial reporting as distributed via public financial data platforms; company news and stock commentary from specialist defence sector financial publications; general financial market data aggregators providing price, moving average, and valuation data.
Data correct as of 2026-04-27.